Kong AN - Search Results

1

Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.

Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN. Li W, et al. Among authors: kong an. Biochem Pharmacol. 2008 Dec 1;76(11):1485-9. doi: 10.1016/j.bcp.2008.07.017. Epub 2008 Jul 23. Biochem Pharmacol. 2008. PMID: 18694732 Free PMC article. Review.

2

Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC).

Keum YS, Owuor ED, Kim BR, Hu R, Kong AN. Keum YS, et al. Among authors: kong an. Pharm Res. 2003 Sep;20(9):1351-6. doi: 10.1023/a:1025737622815. Pharm Res. 2003. PMID: 14567627

3

Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms.

Keum YS, Jeong WS, Kong AN. Keum YS, et al. Among authors: kong an. Mutat Res. 2004 Nov 2;555(1-2):191-202. doi: 10.1016/j.mrfmmm.2004.05.024. Mutat Res. 2004. PMID: 15476860 Review.

4

Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.

Reddy BS, Wang CX, Kong AN, Khor TO, Zheng X, Steele VE, Kopelovich L, Rao CV. Reddy BS, et al. Among authors: kong an. Cancer Res. 2006 Apr 15;66(8):4542-6. doi: 10.1158/0008-5472.CAN-05-4428. Cancer Res. 2006. PMID: 16618783

5

Induction of heme oxygenase-1 (HO-1) and NAD[P]H: quinone oxidoreductase 1 (NQO1) by a phenolic antioxidant, butylated hydroxyanisole (BHA) and its metabolite, tert-butylhydroquinone (tBHQ) in primary-cultured human and rat hepatocytes.

Keum YS, Han YH, Liew C, Kim JH, Xu C, Yuan X, Shakarjian MP, Chong S, Kong AN. Keum YS, et al. Among authors: kong an. Pharm Res. 2006 Nov;23(11):2586-94. doi: 10.1007/s11095-006-9094-2. Epub 2006 Oct 18. Pharm Res. 2006. PMID: 17048120

6

Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis.

Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN. Khor TO, et al. Among authors: kong an. Cancer Res. 2006 Dec 15;66(24):11580-4. doi: 10.1158/0008-5472.CAN-06-3562. Cancer Res. 2006. PMID: 17178849

7

Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.

Nair S, Hebbar V, Shen G, Gopalakrishnan A, Khor TO, Yu S, Xu C, Kong AN. Nair S, et al. Among authors: kong an. Pharm Res. 2008 Feb;25(2):387-99. doi: 10.1007/s11095-007-9364-7. Epub 2007 Jul 27. Pharm Res. 2008. PMID: 17657594

8

Targeting carcinogen metabolism by dietary cancer preventive compounds.

Yu S, Kong AN. Yu S, et al. Among authors: kong an. Curr Cancer Drug Targets. 2007 Aug;7(5):416-24. doi: 10.2174/156800907781386669. Curr Cancer Drug Targets. 2007. PMID: 17691900 Review.

9

Pharmacogenomic profile of soy isoflavone concentrate in the prostate of Nrf2 deficient and wild-type mice.

Barve A, Khor TO, Nair S, Lin W, Yu S, Jain MR, Chan JY, Kong AN. Barve A, et al. Among authors: kong an. J Pharm Sci. 2008 Oct;97(10):4528-45. doi: 10.1002/jps.21311. J Pharm Sci. 2008. PMID: 18236473

10

Molecular mechanisms of Nrf2-mediated antioxidant response.

Li W, Kong AN. Li W, et al. Among authors: kong an. Mol Carcinog. 2009 Feb;48(2):91-104. doi: 10.1002/mc.20465. Mol Carcinog. 2009. PMID: 18618599 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters